The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...

As part of a move to extend its reach in patient monitoring, Franklin Lakes-headquartered medtech Becton, Dickinson and Co. (BD) plans to acquire Edwards Lifesciences’ smart connected care business.

We’re starting to see some countries and municipalities declare the pandemic as “over” and Covid-19 testing as a routine part of life. I’m not sure any of us can predict the answer to the question, ...

BD (BDX), the MedTech firm also known as Becton, Dickinson, traded lower in the premarket on Monday despite posting better-than-expected financials for Q1 fiscal 2026, as its life sciences segment ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

FRANKLIN LAKES, N.J., Aug. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named ...

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...

Becton, Dickinson and Company (BD) is moving up two of its senior staffers into major roles for the medtech company as its chief technology officer John DeFord is set to retire at year-end. Patrick ...